Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma

Clinical trial NCT02601209 · TERMINATED

Trial details

NCT number: NCT02601209
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

High Grade Sarcoma Metastatic Leiomyosarcoma Metastatic Malignant Peripheral Nerve Sheath Tumor Metastatic Synovial Sarcoma Metastatic Undifferentiated Pleomorphic Sarcoma Metastatic Unresectable Sarcoma Myxofibrosarcoma Recurrent Leiomyosarcoma Recurrent Malignant Peripheral Nerve Sheath Tumor Recurrent Synovial Sarcoma Recurrent Undifferentiated Pleomorphic Sarcoma Stage III Uterine Corpus Leiomyosarcoma AJCC v8

Start date: 2015-11-30
Primary completion: 2018-12-07
Enrollment: 151

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.